- $18.91m
- -$46.41m
Annual balance sheet for Q32 Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 217 | 156 | 175 | 82.7 | 78 |
| Net Total Receivables | — | — | — | — | 0.555 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 220 | 192 | 181 | 83.9 | 81.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 42.9 | 17.9 | 21.6 | 0.65 | 7.09 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 264 | 212 | 228 | 84.6 | 92.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 22.7 | 17.2 | 22.6 | 11.6 | 16.5 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 67.7 | 42.1 | 50.5 | 11.6 | 86.7 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 196 | 170 | 178 | 73 | 5.67 |
| Total Liabilities & Shareholders' Equity | 264 | 212 | 228 | 84.6 | 92.3 |
| Total Common Shares Outstanding |